International Development News
Development News Edition

Reuters Health News Summary


Following is a summary of current health news briefs.

Tall people may be more prone to varicose veins

Standing above the crowd puts people at greater risk of developing varicose veins, a large genetic study suggests. Varicose veins are swollen, twisted veins that can be seen just under the surface of the skin, usually in the legs. More than 30 million people in the U.S. have varicose veins. Although the condition is often dismissed as nothing more than a cosmetic nuisance, it can cause moderate pain and has been linked to the more serious side effect of deep vein thrombosis, or blood clots in the deep veins in the body.

Pharmacies still blocking U.S. teens looking for emergency contraception

Teens seeking to buy emergency contraception at pharmacies continue to face significant roadblocks, a new U.S. study suggests. Researchers checking on the accessibility of the "morning after pill" at pharmacies in four Southwestern states found that just 28 percent made it simple and straightforward for teens to purchase the emergency contraception, according to the results published in the Journal of Adolescent Health.

Uganda begins Ebola vaccinations amid Congo transmission fears

Uganda says it will start to vaccinate some of its health workers against Ebola on Monday, amid fears that the viral haemorrhagic fever could spread from Democratic Republic of Congo which is battling an outbreak. The East African country has suffered regular outbreaks of Ebola and Marburg over the years, both high-fatality viral haemorrhagic fevers.

FDA approves Pfizer's treatment for certain lung cancer patients

Pfizer Inc said on Friday the U.S. Food and Drug Administration has approved its lung-cancer treatment for patients with a specific gene mutation who had been previously treated for an aggressive form of the disease. The treatment, Lorbrena, is designed to treat advanced non-small cell lung cancer in patients with a mutation of the ALK gene, who have relapsed after being treated with ALK inhibitors, such as Pfizer's Xalkori.

Novartis abandons effort for U.S. approval of biosimilar rituximab

Novartis International AG said on Friday that its Sandoz division is abandoning an effort to gain U.S. regulatory approval for a biosimilar of rituximab, a medication used to treat certain cancer and rheumatoid arthritis. The decision comes after the U.S. Food and Drug Administration (FDA) sought additional information to support the company's application for the drug, which is approved already in the EU, Switzerland, Japan and Australia, the company said in a statement.

FDA approves AcelRx Pharma's opioid pain drug

The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based treatment for pain to be used under strict medical supervision, with the agency's chief highlighting reasons for the approval in a rare move. The regulator's decision comes as the U.S. opioid crisis reaches epidemic levels, claiming lives of an estimated 130 Americans a day on average, according to the U.S. Centers for Disease Control and Prevention.

Trevena opioid painkiller fails to win FDA approval, shares plunge

Trevena Inc shares plunged 45 percent on Friday after the U.S. Food and Drug Administration declined to approve its opioid injection for managing acute pain, citing inadequate safety data. The widely expected rejection comes after a panel of experts to the FDA voted against the approval of the drug due to lack of safety data and potential for abuse, at a time when opioid addiction in the country has reached epidemic proportions.

FDA panel recommends Sage's postpartum depression treatment

An advisory panel to the U.S. Food and Drug Administration on Friday recommended Sage Therapeutics Inc's experimental treatment for postpartum depression, saying the benefits of the drug outweighed risks. The panel voted 17-1 in favor of the injectable treatment, Zulresso, which aims to treat major episodes of depression during pregnancy or within four weeks of delivery.

AbbVie, Roche combo treatment meets main goal of leukemia trial

AbbVie Inc and Roche Holding AG said on Wednesday their targeted therapy delayed the progression of a type of blood and bone marrow cancer when used in combination with the Swiss drugmaker's cancer drug in a late-stage trial. The drug, Venclexta, when used with Roche's Gazyva, showed a statistically significant reduction in the risk of disease worsening or death in patients with chronic lymphocytic leukemia (CLL), when compared to the standard of care, Roche said.

E-therapy may help ease insomnia

People with insomnia who receive a digitized version of cognitive behavioral therapy (CBT) as part of their treatment may find more symptom relief than those who only receive tips to improve their sleep routines, a recent experiment suggests. Researchers randomly assigned 1,700 insomnia patients to receive either digital CBT or so-called sleep hygiene education designed to improve bedtime routines and encourage avoidance of substances like caffeine and alcohol that can interfere with sleep.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION/BLOG/INTERVIEW

How music can help expectant mothers during pregnancy

Music provides pleasant ambience for all but its more important for expectant mothers as besides ensuring pleasant environment for them it also directly and indirectly influences the unborn babies. There are various scientific findings to c...

EdTech: A technical approach to flexible and cost-effective education

Its hight time for the world to go for innovative approaches like e-learning over traditional learning methods that need physical infrastructure, long-term planning, and huge investment. ...

Our school campaigns are our strongest ally: Joaquin Antuna, founder of Peace and Cooperation

Joaquin Antuna is the founder of Peace and Cooperation, a Spanish NGO which was nominated as peace messenger by the United Nations in 1986. Antuna is of very firm opinion that in order to have an incisive impact on the community we live in,...

'No escape from telephones', this 1953 prediction actually comes true

In 1953, a telephone company chief predicted that therell be no escape from telephones in the future....

Videos

Latest News

Emirates slims Boeing purchase plans amid 777X delays

Emirates Airline on Wednesday slimmed down its purchasing plans with Boeing amid delays in delivering an order of 156 of the new long-range 777X aircraft, substituting instead 30 of its 787-9 Dreamliners. The Middle Easts largest airline in...

EU says France, Italy's 2020 draft budgets at risk of breaching fiscal rules

The European Commission said on Wednesday that draft budgets for next year prepared by the French and Italian governments were at risk of violating European Union fiscal rules as they could miss their debt and deficit reduction targets.The ...

Iranian dual nationals among those arrested during petrol price hike unrest- Fars news

Iranian dual nationals are among those arrested since last week during unrest over a petrol price hike, the semi-official Fars news agency reported on Wednesday.Citing security sources, Fars reported that detained German, Turkish and Afghan...

Telcos have to pay Rs 1.47 lakh cr in past dues; no proposal to waive off interest, penalty: Prasad

Bharti Airtel, Vodafone Idea and other telecom companies owe the government as much as Rs 1.47 lakh crore in past statutory dues, Telecom Minister Ravi Shankar Prasad told Parliament on Wednesday adding that there is no proposal at present ...

Give Feedback